 Treatment evaluation experimental staphylococcal infections comparison beta-lactam lipopeptide glycopeptide antimicrobial therapy LY teicoplanin vancomycin oxacillin cephalothin cefamandole ampicillin sulbactam cefoperazone sulbactam isolates staphylococci Staphylococcus aureus coagulase negative staphylococci vivo vitro methods vitro susceptibility measurements isolates sensitive vancomycin isolates sensitive cefamandole ampicillin sulbactam cefoperazone sulbactam Comparison antimicrobial therapy vivo rabbit model cefoperazone sulbactam active number isolates reduction equal colony units milliliter CFU/ml growth control end animal treatment study Vancomycin oxacillin equal reductions equal CFU/ml isolates isolate vivo outcome vitro data shows vitro susceptibility tests sensitivity isolates vancomycin variable teicoplanin cefamandole ampicillin sulbactam cefoperazone sulbactam underpredict oxacillin